Role of the tumor board when prescribing mutant isocitrate dehydrogenase inhibitors to patients with isocitrate dehydrogenase-mutant glioma.
Saved in:
| Title: | Role of the tumor board when prescribing mutant isocitrate dehydrogenase inhibitors to patients with isocitrate dehydrogenase-mutant glioma. |
|---|---|
| Authors: | Roth, Patrick1,2 (AUTHOR), Capper, David3,4 (AUTHOR), Calabrese, Evan5 (AUTHOR), Halasz, Lia M6 (AUTHOR), Jakola, Asgeir S7,8 (AUTHOR) |
| Source: | Neuro-Oncology Practice. 2025 Supplement, Vol. 12, pi29-i37. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 182369596 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Role of the tumor board when prescribing mutant isocitrate dehydrogenase inhibitors to patients with isocitrate dehydrogenase-mutant glioma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Roth%2C+Patrick%22">Roth, Patrick</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Capper%2C+David%22">Capper, David</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Calabrese%2C+Evan%22">Calabrese, Evan</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Halasz%2C+Lia+M%22">Halasz, Lia M</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jakola%2C+Asgeir+S%22">Jakola, Asgeir S</searchLink><relatesTo>7,8</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Neuro-Oncology+Practice%22">Neuro-Oncology Practice</searchLink>. 2025 Supplement, Vol. 12, pi29-i37. 9p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=182369596 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/nop/npae100 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 9 StartPage: i29 Titles: – TitleFull: Role of the tumor board when prescribing mutant isocitrate dehydrogenase inhibitors to patients with isocitrate dehydrogenase-mutant glioma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Roth, Patrick – PersonEntity: Name: NameFull: Capper, David – PersonEntity: Name: NameFull: Calabrese, Evan – PersonEntity: Name: NameFull: Halasz, Lia M – PersonEntity: Name: NameFull: Jakola, Asgeir S IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 02 Text: 2025 Supplement Type: published Y: 2025 Identifiers: – Type: issn-print Value: 20542577 Numbering: – Type: volume Value: 12 Titles: – TitleFull: Neuro-Oncology Practice Type: main |
| ResultId | 1 |